Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2002-1-21
pubmed:abstractText
We have previously reported the isolation of the human matrix metalloproteinase (MMP)-19 (also referred to as RASI) from a synovium of a patient suffering from rheumatoid arthritis and its expression at the cell surface of activated PBMC. In this study, we have analyzed the regulation and cell surface expression of human MMP-19 in several human cell lines and blood-derived cells. Among the cell lines analyzed, MMP-19 is largely expressed by lung fibroblasts as well as by myeloid cell lines THP-1 and HL-60. After fractionating PBMC into CD14- and CD14+ populations we found that only the latter one expresses MMP-19. Although the myeloid cell lines as well as CD14+ cells express MMP-19 without stimulation, its production can be up-regulated by phorbol esters (PMA) or by adhesion. The adhesion-dependent expression was down-regulated or even abrogated by blockade of adhesion or interfering with adhesion-controlling signaling using alpha-tocopherol. We have shown that MMP-19 associates with the cell surface of myeloid cells. This cell surface association was not affected by phospholipase C. However, acidic treatment of the THP-1-derived cell membranes abolished the immunoprecipitation of MMP-19 thereof. Moreover, a high salt treatment of THP-1 cells diminished the MMP-19 detection on the cell surface. This implicates a noncovalent attachment of MMP-19 to the cell surface. Because a truncated form of the MMP-19, in which the hemopexin-like domain was deleted (Delta(hp)MMP-19), does not associate with the surface, the hemopexin-like domain appears to be critical for the cell surface attachment of human MMP-19.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
168
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1244-51
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11801661-Amino Acid Sequence, pubmed-meshheading:11801661-Antigens, CD14, pubmed-meshheading:11801661-Cell Adhesion, pubmed-meshheading:11801661-Cell Differentiation, pubmed-meshheading:11801661-Cell Fractionation, pubmed-meshheading:11801661-Cell Line, pubmed-meshheading:11801661-Cell Membrane, pubmed-meshheading:11801661-Gene Expression Profiling, pubmed-meshheading:11801661-Gene Expression Regulation, Enzymologic, pubmed-meshheading:11801661-HL-60 Cells, pubmed-meshheading:11801661-HeLa Cells, pubmed-meshheading:11801661-Hemopexin, pubmed-meshheading:11801661-Humans, pubmed-meshheading:11801661-Jurkat Cells, pubmed-meshheading:11801661-Leukocytes, Mononuclear, pubmed-meshheading:11801661-Matrix Metalloproteinases, Secreted, pubmed-meshheading:11801661-Metalloendopeptidases, pubmed-meshheading:11801661-Molecular Sequence Data, pubmed-meshheading:11801661-Myeloid Cells, pubmed-meshheading:11801661-Up-Regulation
pubmed:year
2002
pubmed:articleTitle
Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface.
pubmed:affiliation
Department of Immunology, University of Konstanz, Konstanz, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't